Poly Medicure share news, announcements and annual reports
NSE: POLYMEDBSE: 531768Healthcare Equipment & SuppliesSmall Cap
Poly Medicure Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1996 on BSE, Dec 2011 on NSE
Last close ₹1,476.00up ₹6.00 (0.41%)BSE ₹1,478.60
Share price at the NSE close on 28 Oct 2026. Previous close ₹1,470.00.
28 Oct: open ₹1,465.00, high ₹1,489.90, low ₹1,454.90
52-week range of traded prices to 28 Oct 2026
₹1,182.00Low, 30 Mar 2026₹2,094.30High, 11 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹14,961 Cr425th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 47.48
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.82
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.24%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 9.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.11
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 73,75269.7% delivered
Poly Medicure board meetings
111 filed, newest first. Page 3 of 3.
Oct 2013
14 Oct · Board meeting
To consider and approve Inter-alia, Un-audited Financial Results of the Company for the quarter ended On September 30, 2013.
Jul 2013
22 Jul · Board meeting
To consider & approve Un-Audited Financial Results for the quarter ended on 30th June, 2013
Apr 2013
19 Apr · Board meeting
To consider and approve, inter alia, Annual Audited Financial Results of the Company and to recommend payment of Dividend, if any, for the Financial Year 2012-13.
Jan 2013
17 Jan · Board meeting
To consider and approve, inter alia, Un-audited Financial Results of the Company for the quarter ended on December 31, 2012.
Oct 2012
17 Oct · Board meeting
To consider and approve, inter alia, Un-audited Financial Results of the Company for the quarter ended on September 30, 2012.
Jul 2012
20 Jul · Board meeting
To consider and approve, inter alia, Un-Audited Financial Results of the Company for the quarter ended on June 30, 2012.
Jun 2012
11 Jun · Board meeting
Board of Directors of the Company at its meeting held on May 28, 2012, have approved the following business : (1) Induction of Shri Shailendra Raj Mehta, as an Additional Director in the capacity of the Non Executive, Independent Director on the Board with immediate effect.
May 2012
18 May · Board meeting
Company had informed the Exchange that a meeting of the Board of Directors of the Company Scheduled to be held on May 19, 2012 to consider and approve, inter alia, Audited Financial Results of the Company and to recommend payment of dividend, if any, for the Financial Year 2011-12.The Company has now informed the Exchange that the Company have rescheduled the said Board Meeting and the same shall be now held on May 28, 2012 inter-alia to consider the following business : (1) To consider and approve Audited Financial Results for the year ended on March 31, 2012. (2) To consider recommendation of dividend, if any, for the Financial Year 2011-12.Not held on this date
8 May · Board meeting
To consider and approve, inter alia, Audited Financial Results of the Company and to recommend payment of dividend, if any, for the Financial Year 2011-12.
Jan 2012
16 Jan · Board meeting
Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on January 31, 2012 to consider inter -alia, Unaudited Financial Results for the quarter ended December 31, 2011. The Company has now informed the Exchange that the Company have rescheduled the aforesaid Board Meeting and the same shall be now held on January 30, 2012.Not held on this date
12 Jan · Board meeting
To consider inter -alia, Unaudited Financial Results for the quarter ended December 31, 2011.